ClinicalTrial | Financial Buzz

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Alector, Inc. (NASDAQ: ALEC) Immuno-Neurology Development Collaboration With GSK

financial buzz07/02/2021

1745

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Alector, Inc. Shares Climb Following Immuno-Neurology Development Collaboration With GSK” Alector, Inc (NASDAQ: ALEC) surged over 39% in...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Cerevel Therapeutics (NASDAQ: CERE) Results for CVL-231 in Phase 1b Clinical Trial

financial buzz06/29/2021

1824

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Cerevel Therapeutics Sees Positive Results for CVL-231 in Phase 1b Clinical Trial” Cerevel Therapeutics (NASDAQ: CERE) surged over...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Geron Corporation (NASDAQ: GERN) IMbark Phase 2 Data: Journal of Clinical Oncology

financial buzz06/18/202106/18/2021

2620

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Geron Corporation Announces Publication of IMbark Phase 2 Data in Journal of Clinical Oncology” Geron Corporation (NASDAQ: GERN)...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Moderna Requests FDA Approval to Vaccinate Kids 12 to 17

Rebecca Urena06/10/202106/10/2021

3212

Moderna (NASDAQ: MRNA), an American pharmaceutical and biotechnology company, has requested that the Food and Drug Administration grant it emergency use of its Covid-19 vaccine in kids ages 12...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products Technology The Market Buzz Your Environment

Biogen Receives FDA Approval for Alzheimer’s Drug

Rebecca Urena06/07/202106/07/2021

2619

On Monday, The Food and Drug Administration, approved Biogen’s (NASDAQ: BIIB) Alzheimer’s disease drug aducanumab. The medication, which delays the cognitive decline in patients with Alzheimer’s, is the first...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products Technology The Market Buzz Your Environment

Moderna Applies for Full FDA Approval of its COVID-19 Vaccine

Rebecca Urena06/01/202106/01/2021

3002

Moderna (NASDAQ: MRNA), an American pharmaceutical, announced it has applied for full approval from the Food and Drug Administration for its Covid-19 vaccine. It is the second U.S. drugmaker...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

UK Authorizes Janssen Covid Vaccine for Use

Rebecca Urena05/28/202105/28/2021

2013

Johnson & Johnson’s (NYSE: JNJ) Janssen Covid-19 vaccine was approved by the U.K.’s medicines regulator on Friday. According to Britain’s Medicines and Healthcare products Regulatory Agency, the shots should...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Iterum Therapeutics (NASDAQ: ITRM) Provides Update on FDA Review

financial buzz05/28/202105/28/2021

2104

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Iterum Therapeutics Surges Following FDA Late-Cycle Meeting” Iterum Therapeutics plc (NASDAQ: ITRM) surged over 17% in premarket trading...

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

Larimar Therapeutics FDA Clinical Hold on CTI-1601 and Termination of Recent Financing

David Kim05/26/2021

2827

Larimar Therapeutics, Inc. (NASDAQ: LRMR) has reported that the U.S. FDA has placed a clinical hold on the CTI-1601 clinical program and the company will not close its previously...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Moderna Seeks FDA Authorization Amid Effective Covid Vaccine in Teens

Rebecca Urena05/25/202105/25/2021

2499

Moderna (NASDAQ: MRNA) announced Tuesday that its Covid-19 vaccine was 93% to 100% effective on adolescents from ages 12-17. The company is now the second biopharmaceutical to exhibit high...

Tag: ClinicalTrial

“The Buzz” Show: Alector, Inc. (NASDAQ: ALEC) Immuno-Neurology Development Collaboration With GSK

“The Buzz” Show: Cerevel Therapeutics (NASDAQ: CERE) Results for CVL-231 in Phase 1b Clinical Trial

“The Buzz” Show: Geron Corporation (NASDAQ: GERN) IMbark Phase 2 Data: Journal of Clinical Oncology

Moderna Requests FDA Approval to Vaccinate Kids 12 to 17

Biogen Receives FDA Approval for Alzheimer’s Drug

Moderna Applies for Full FDA Approval of its COVID-19 Vaccine

UK Authorizes Janssen Covid Vaccine for Use

“The Buzz” Show: Iterum Therapeutics (NASDAQ: ITRM) Provides Update on FDA Review

Larimar Therapeutics FDA Clinical Hold on CTI-1601 and Termination of Recent Financing

Moderna Seeks FDA Authorization Amid Effective Covid Vaccine in Teens

ABOUT US

Tweets